The Role of Cytogenetics in Genetic Disorders

Boles Zou^*
*Correspondence: Boles Zou, Department of Pathology and Cell Biology, Columbia University, NY 10032, USA, Email:

Introduction

Cytogenetic plays a crucial role in the diagnosis, understanding, and treatment of various genetic disorders. It is a branch of genetics that focuses on the study of chromosomes, their structure, function, and behavior. Cytogenetics allows researchers and clinicians to observe chromosomal abnormalities, which can result in a wide range of diseases. These abnormalities may include changes in the number or structure of chromosomes, such as duplications, deletions, translocations, or inversions, all of which can lead to genetic disorders. The study of cytogenetic is integral to identifying the underlying causes of genetic diseases and provides insights into their pathogenesis, potential treatments, and management strategies.

In humans, the typical chromosome number is 46, arranged in 23 pairs. These chromosomes carry the genetic information necessary for the development, growth, and function of the body. Any alteration in the number or structure of chromosomes can result in a genetic disorder. Cytogenetic techniques, including karyotyping, Fluorescence In Situ Hybridization (FISH), and chromosomal microarray analysis, have revolutionized the ability to detect and analyze such chromosomal abnormalities. Karyotyping, one of the most commonly used methods, involves the examination of the complete set of chromosomes under a microscope. It allows for the identification of large chromosomal abnormalities such as trisomies or monosomies, which are associated with disorders like Down syndrome, Turner syndrome, and Klinefelter syndrome [1].

Description

FISH, on the other hand, is a more advanced technique that uses fluorescent probes to detect specific sequences of DNA, enabling the detection of smaller chromosomal changes or structural rearrangements. Chromosomal microarray analysis, a high-resolution method, allows for the detection of subtle genetic imbalances such as microdeletions or microduplications, which may not be visible through traditional karyotyping [2]. Genetic disorders resulting from chromosomal abnormalities can be classified into two broad categories: numerical and structural abnormalities. Numerical abnormalities involve changes in the number of chromosomes. One of the most well-known examples of numerical chromosomal abnormalities is Down syndrome, also known as trisomy 21. This condition occurs when an individual has three copies of chromosome 21 instead of the usual two, leading to intellectual disability, developmental delays, and other physical characteristics such as a flattened face and upward-slanting eyes [3].

Other numerical abnormalities include trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome), both of which are associated with severe developmental delays and high rates of mortality in early childhood. On the opposite end of the spectrum, monosomies, where one chromosome is missing, are also associated with genetic disorders, such as Turner syndrome. This condition occurs when a female is born with only one X chromosome instead of two, leading to short stature, infertility, and various other physical and developmental issues [4]. Structural chromosomal abnormalities involve alterations in the structure of chromosomes, such as deletions, duplications, inversions, or translocations. These abnormalities can have significant consequences for an individual’s health, depending on the specific genes affected. One of the most studied structural abnormalities is the deletion of a portion of chromosome 5, known as Cri-du-chat syndrome. This disorder is characterized by a high-pitched cry resembling a cat’s meow, intellectual disability, delayed development, and distinctive facial features.

Deletions or duplications of small chromosomal regions can also be implicated in conditions such as Di-George syndrome, Williams’s syndrome, and Prader-Willi syndrome. Another example of structural abnormalities is translocations, where a part of one chromosome is exchanged with a part of another chromosome. These rearrangements can lead to conditions such as Chronic Myelogenous Leukemia (CML), which is caused by the translocation between chromosomes 9 and 22, resulting in the formation of the Philadelphia chromosome [5]. The field of cytogenetic has not only provided insights into the mechanisms behind genetic disorders but has also paved the way for more precise and personalized treatment approaches. For example, in cases of chromosomal translocations leading to cancers such as CML, targeted therapies that specifically address the genetic abnormality, such as tyrosine kinase inhibitors like imagine, have revolutionized treatment.

By understanding the specific genetic changes driving the disease, clinicians can offer treatments tailored to the individual’s unique genetic makeup. Cytogenetic testing is also essential in prenatal diagnosis, where it can be used to detect chromosomal abnormalities in a fetus. Techniques such as amniocentesis and chorionic villus sampling allow for the analysis of fetal cells to detect conditions like Down syndrome and other chromosomal disorders before birth, enabling families to make informed decisions about pregnancy management. Furthermore, the role of cytogenetic extends beyond the detection of genetic disorders to the exploration of the genetic basis of complex diseases. Many multifactorial diseases, including some forms of cancer, heart disease, and mental health disorders, may involve subtle chromosomal abnormalities that are difficult to detect using traditional genetic methods.

In addition to its clinical applications, cytogenetic is also critical in the field of genetic counseling. Genetic counselors use cytogenetic data to help individuals and families understand the risk of inheriting genetic disorders. By examining family history and conducting genetic testing, they can provide advice on the likelihood of passing on chromosomal abnormalities to offspring. This is especially important in cases where one or both parents carry balanced chromosomal rearrangements, which may not cause any health problems in the carrier but can result in an increased risk of having a child with an unbalanced chromosomal abnormality. In such cases, cytogenetic testing can help determine the best course of action for family planning and reproductive decisions.

Conclusion

In conclusion, cytogenetic plays an essential role in understanding and addressing genetic disorders. Through the study of chromosomes and the identification of chromosomal abnormalities, cytogenetic has enhanced our ability to diagnose, manage, and treat a wide range of genetic conditions. From numerical abnormalities like Down syndrome to structural rearrangements that cause conditions like CML, cytogenetic provides valuable insights into the genetic basis of these diseases. Moreover, the integration of cytogenetic techniques with other molecular technologies has the potential to revolutionize the field of genetics, offering new opportunities for precision medicine and personalized treatments. As research in cytogenetics continues to progress, it holds the promise of improving the lives of individuals affected by genetic disorders and advancing our understanding of the complex relationship between genes and health.

Acknowledgment

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Treger, Taryn Dora, Tanzina Chowdhury, Kathy Pritchard-Jones and Sam Behjati. "The genetic changes of wilms tumour." Nat Rev Nephrol 15 (2019): 240-251.

   Google Scholar, Crossref, Indexed at

2. Grade, Marian, Michael J. Difilippantonio and Jordi Camps. "Patterns of chromosomal aberrations in solid tumors." Chromosomal Instability Cancer Cells (2015): 115-142.

   Google Scholar, Crossref, Indexed at

3. Heng, H. H. Q., G. Liu, J. B. Stevens and B. Y. Abdallah, et al. "Karyotype heterogeneity and unclassified chromosomal abnormalities." Cytogenet Genome Res 139 (2013): 144-157.

   Google Scholar, Crossref, Indexed at

4. Larson, Daniel P., Yassmine M. Akkari, Daniel L. Van Dyke and Gordana Raca, et al. "Conventional cytogenetic analysis of hematologic neoplasms: A 20-year review of proficiency test results from the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee." Arch Pathol Lab Med 145 (2021): 176-190.

   Google Scholar, Crossref, Indexed at

5. Hol, Janna A., Marjolijn CJ Jongmans, Hélène Sudour‐Bonnange and Gema L. Ramírez‐Villar, et al. "Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30‐year SIOP‐RTSG experience." Cancer 127 (2021): 628-638.

   Google Scholar, Crossref, Indexed at